Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dawn Livingstone is active.

Publication


Featured researches published by Dawn Livingstone.


Endocrinology | 2000

Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats

Dawn Livingstone; Gregory C. Jones; Kenneth Smith; Pauline Jamieson; Ruth Andrew; Christopher J. Kenyon; Brian R. Walker

The role of glucocorticoids in obesity is poorly understood. Observations in obese men suggest enhanced inactivation of cortisol by 5alpha-reductase and altered reactivation of cortisone to cortisol by 11betahydroxysteroid dehydrogenase type 1 (11betaHSD1). These changes in glucocorticoid metabolism may influence corticosteroid receptor activation and feedback regulation of the hypothalamic-pituitary-adrenal axis (HPA). We have compared corticosterone metabolism in vivo and in vitro in male obese and lean Zucker rats, aged 9 weeks (n = 8/group). Steroids were measured in 72-h urine and 0900 h trunk blood samples. 5alpha-Reductase type 1 and 11betaHSD activities were assessed in dissected tissues. Obese animals were hypercorticosteronemic and excreted more total corticosterone metabolites (2264+/-623 vs. 388+/-144 ng/72 h; P = 0.003), with a greater proportion being 5alpha-reduced or 11-oxidized. 11-Dehydrocorticosterone was also elevated in plasma (73+/-9 vs. 18+/-2 nM; P = 0.001) and urine (408+/-111 vs. <28 ng/72 h; P = 0.01). In liver of obese rats, 5alpha-reductase type 1 activity was greater (20.6+/-2.7% vs. 14.1+/-1.5%; P<0.04), but 11betaHSD1 activity (maximum velocity, 3.43+/-0.56 vs. 6.57+/-1.13 nmol/min/mg protein; P = 0.01) and messenger RNA levels (0.56+/-0.08 vs. 1.03+/-0.15; P = 0.02) were lower. In contrast, in obese rats, 11betaHSD1 activity was not different in skeletal muscle and sc fat and was higher in omental fat(36.4+/-6.2 vs. 19.2+/-6.6; P = 0.01), whereas 11betaHSD2 activity was higher in kidney (16.7+/-0.6% vs. 11.3+/-1.5%; p = 0.01). We conclude that greater inactivation of glucocorticoids by 5alpha-reductase in liver and 11betaHSD2 in kidney combined with impaired reactivation of glucocorticoids by 11betaHSD1 in liver may increase the MCR of glucocorticoids and decrease local glucocorticoid concentrations at these sites. By contrast, enhanced 11betaHSD1 in omental adipose tissue may increase local glucocorticoid receptor activation and promote obesity.


The Journal of Clinical Endocrinology and Metabolism | 2003

Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians

Robert S. Lindsay; Deborah J. Wake; Saraswathy Nair; Joy C. Bunt; Dawn Livingstone; Paska A. Permana; P. Antonio Tataranni; Brian R. Walker


The Journal of Clinical Endocrinology and Metabolism | 2003

Local and Systemic Impact of Transcriptional Up-Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue in Human Obesity

Deborah J. Wake; Eva Rask; Dawn Livingstone; Stefan Söderberg; Tommy Olsson; Brian R. Walker


Endocrinology | 2005

Reduced Adipose Glucocorticoid Reactivation and Increased Hepatic Glucocorticoid Clearance as an Early Adaptation to High-Fat Feeding in Wistar Rats

Amanda J Drake; Dawn Livingstone; Ruth Andrew; Jonathan R. Seckl; Nicholas M. Morton; Brian R. Walker


Society for Endocrinology BES 2017 | 2017

Improving the therapeutic index of topical anti-inflammatory steroids: angiostatic effects of 5[alpha]-tetrahydrocorticosterone vs hydrocortisone

Amber J. Abernethie; Giorgia Maltese; Dawn Livingstone; Annalisa Gastaldello; Ruth Morgan; Brian R. Walker; Patrick Hadoke; Ruth Andrew


Society for Endocrinology BES 2015 | 2015

5[alpha]-tetrahydrocorticosterone exhibits topical anti-inflammatory action with limited adverse effects on angiogenesis

Annalisa Gastaldello; Dawn Livingstone; Nicola Tsang; Brian R. Walker; Patrick Hadoke; Ruth Andrew


Society for Endocrinology BES 2015 | 2015

Hyperinsulinaemia due to inhibition of 5[alpha]-reductases is ameliorated by liver-selective glucocorticoid receptor antagonism in diet-induced obesity

Tracy C S Mak; Dawn Livingstone; Brian R. Walker; Ruth Andrew


Society for Endocrinology BES 2013 | 2013

Transgenic disruption of 5α-reductase 1 increases susceptibility to liver fibrosis

Dawn Livingstone; Georgina Rees; Benjamin Weldin; David P. Macfarlane; Brian R. Walker; Ruth Andrew


Archive | 2013

Association of Physicians Annual Meeting

Ruth Andrew; Rita Upreti; Dawn Livingstone; Pascal Barat; Kate Hughes; David P. Macfarlane; Calum Gray; Fiona C. Minns; Ian Marshall; Laura Stewart; Brian R. Walker


Society for Endocrinology BES 2012 | 2012

Ageing and social isolation increase susceptibility to anxiety in mice lacking 5[alpha]-reductase type 1

Rollo Emma Di; Dawn Livingstone; Brian R. Walker; Ruth Andrew

Collaboration


Dive into the Dawn Livingstone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ruth Andrew

Western General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenneth Smith

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Patrick Hadoke

Western General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge